XORTX Therapeutics Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for XORTX Therapeutics Inc. (XRTX) is 841.87K

According to XORTX Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 841.87K. This represents a change of -68.80% compared to the average of 2.70M of the last 4 quarters.

XORTX Therapeutics Inc. (XRTX) Historical Enterprise Value (quarterly & annually)

How has XRTX Enterprise Value performed in the past?

The mean historical Enterprise Value of XORTX Therapeutics Inc. over the last ten years is 2.35M. The current 841.87K Enterprise Value has changed -64.16% with respect to the historical average. Over the past ten years (40 quarters), XRTX's Enterprise Value was at its highest in in the March 2022 quarter at 142.82M. The Enterprise Value was at its lowest in in the December 2021 quarter at -8479607.93.

XORTX Therapeutics Inc. (XRTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of XORTX Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

XORTX Therapeutics Inc. (XRTX) Average Enterprise Value

How has XRTX Enterprise Value performed in the past?

The current Enterprise Value of XORTX Therapeutics Inc. (XRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

XORTX Therapeutics Inc. (XRTX) Enterprise Value vs. Peers

How is XRTX’s Enterprise Value compared to its peers?

XORTX Therapeutics Inc.’s Enterprise Value is greater than NewcelX Ltd. (810.33K), less than Windtree Therapeutics, Inc. (12.74M), greater than Virax Biolabs Group Limited (-4450886.00), less than NKGen Biotech, Inc. Common Stock (1.44M), greater than Dermata Therapeutics, Inc. (-399046.00), greater than PMGC Holdings Inc. (-2411516.00), greater than Avenue Therapeutics, Inc. (-532150.00), less than Moolec Science S.A. (247.14M), less than GT Biopharma, Inc. (1.73M), less than Lexaria Bioscience Corp. (2.55M),

Build a custom stock screener for XORTX Therapeutics Inc. (XRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XORTX Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

XORTX Therapeutics Inc. (XRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like XORTX Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.